Sulfur dioxide is a fairly ubiquitous air pollutant which forms sulfite when adsorbed to water drop lets. Sulfur dioxide and sulfite are known inducers of bronchoconstriction (Balmes et al. 1987; Fine et al., 1987; Gong et al., 1995) . We have recently shown that long-term exposure of dogs to a neut ral sulfite aerosol representing high am bient levels of sulfur dioxide (corresponding to 0 . 2 ppm sulfur dioxide) induced m oderate inflammatory reac tions in the lungs (Maier et al., 1992) . Reactions included an altered permeability of the alveolarcapillary membrane for proteins, an increased re lease of the lysosomal enzyme ß-N-acetylglucosaminidase as well as an increase in the num ber of neutrophils (PMN), lymphocytes and eosinophils in the epithelial lining fluid (M aier et al., 1992). These alterations are assumed to be triggered by inflammatory mediators including lipid mediators (Evans et al., 1987; O'D onnell and B arnett, 1987; Hayashi et al., 1991; Pinckard et al., 1992; DeLima et al., 1995; Longphre and Kleeberger, 1995) . A l veolar macrophages (AM ) play an im portant role as part of the primary pulmonary defense system releasing such mediators. However, the mecha nisms of interaction between 4-valent sulfur spe cies (sulfur dioxide, sulfite) and cellular compo nents of the lungs remain undefined.
Introduction
Sulfur dioxide is a fairly ubiquitous air pollutant which forms sulfite when adsorbed to water drop lets. Sulfur dioxide and sulfite are known inducers of bronchoconstriction (Balmes et al. 1987; Fine et al., 1987; Gong et al., 1995) . We have recently shown that long-term exposure of dogs to a neut ral sulfite aerosol representing high am bient levels of sulfur dioxide (corresponding to 0 . 2 ppm sulfur dioxide) induced m oderate inflammatory reac tions in the lungs (Maier et al., 1992) . Reactions included an altered permeability of the alveolarcapillary membrane for proteins, an increased re lease of the lysosomal enzyme ß-N-acetylglucosaminidase as well as an increase in the num ber of neutrophils (PMN), lymphocytes and eosinophils in the epithelial lining fluid (M aier et al., 1992) . These alterations are assumed to be triggered by inflammatory mediators including lipid mediators (Evans et al., 1987; O'D onnell and B arnett, 1987; Hayashi et al., 1991; Pinckard et al., 1992; DeLima et al., 1995; Longphre and Kleeberger, 1995) . A l veolar macrophages (AM ) play an im portant role as part of the primary pulmonary defense system releasing such mediators. However, the mecha nisms of interaction between 4-valent sulfur spe cies (sulfur dioxide, sulfite) and cellular compo nents of the lungs remain undefined.
O ur previous in vitro studies on the interaction of sulfite with cells and tissues indicated adverse effects on energy metabolism dependent on the level of sulfite oxidase activity which detoxifies sulfite by oxidation to sulfate (Beck-Speier et al., 1985) . We have further dem onstrated that sulfite modulates the oxidative metabolism of human PMN which are endowed with a very low level of 0939-5075/98/0300-0264 $ 06.00 © 1998 Verlag der Zeitschrift für Naturforschung. All rights reserved. D the sulfite-detoxifying enzyme (Beck-Speier et al., 1993; Beck-Speier et al., 1994; Mishra et al., 1995) . AM and other phagocytic cells exhibit low sulfite oxidase levels, and therefore have a relatively low protective capacity against sulfite (Beck-Speier et al., 1985) . Recently we have found that AM re lease a PM N-stimulating activity with a PAF-like character upon treatm ent with sulfite (BeckSpeier et al., in press ).
To extend our previous studies we investigated the effect of sulfite on the release and generation of proinflam m atory m ediators by AM which m od ulate PMN functions. Freshly isolated AM were treated with sulfite and for comparison with sul fate, and the resulting supernatants containing pu tative m ediators were analyzed for their ability to stimulate the respiratory burst of PMN. M echa nisms of m ediator release were studied by inhibit ing several pathways of lipid metabolism in AM.
Materials and Methods

Materials
Phorbol 12-myristate 13-acetate (PM A), luci genin, leukotriene B4 (LTB4), complement factor 5a (C5a), and quinacrine were purchased from Sigma (Deisenhofen, Germ any); PBS buffer with or without Ca2 +/Mg2+ was from Biochrome (B er lin, Germ any); Polym orphprep was from Nycomed (Oslo, Norway); carrier-free human in terleukin 8 (IL-8 ) was from Biermann (Bad Nauheim, Germ any); platelet-activating factor (PAF), cytochalasin B, A A C O C F3, OBAA, and MK 8 8 6 were from Calbiochem-Novabiochem (Bad Soden, Germ any); indom ethacin was from LC Laboratories/Alexis Deutschland (Grünberg, Germany).
Isolation o f alveolar macrophages
Canine AM were obtained by bronchoalveolar lavage of healthy beagles according to Maier et al. (1992) . A fter bronchoalveolar lavage the cells were obtained by centrifugation (400 x g for 20 min) and resuspension in PBS-buffer (without Ca2 +/Mg2+). Viability was m ore than 95% as de term ined by trypan blue exclusion. Cells were characterized by microscopic examination after May Grünwald Giemsa staining of cytospin prepa rations. 85 to 90% of the cells were identified as AM.
Isolation o f neutrophils
Canine PMN were isolated from citrate-anticoagulated venous blood of healthy beagles by density-gradient centrifugation with Polymorphprep. Blood (5 ml) was layered over Polymorphprep (5 ml) diluted with 1.5% (w/v) NaCl to a density of 1.106 g/ml. A fter centrifugation at 450 x g for 30 min PMN were separated from lymphocytes and monocytes. PMN suspension was washed once with Ca2+-and Mg2+ -free PBS buffer and contam inating erythrocytes were removed by hypotonic lysis according to Beck-Speier et al. (1988) . The pure population of PMN was resuspended in PBSbuffer (without Ca2 +/Mg2+) containing 0.1% glu cose, and viability was more than 95% as deter mined by trypan blue exclusion. Hum an PMN were obtained from citrate-anticoagulated venous blood of healthy donors by density-gradient cen trifugation with Polymorphprep according to Mishra et al. (1995) .
Incubation o f alveolar macrophages with sulfite or sulfate
Canine AM (1 x 106 /ml) were incubated for 30 min at 37 °C in the absence (control) and pres ence of sulfite (0.1-2.0 m M ) or sulfate (1 m M ) , respectively, in PBS buffer, pH 7, containing 0.1% glucose. Sulfite solutions, pH 7, were freshly pre pared by dissolving sodium sulfite in PBS buffer, pH 7, containing 0.1% glucose, and by readjusting the pH value to pH 7 with HCL (Mishra et al. (1995) ). Sulfate solutions, pH 7, were prepared by dissolving sodium sulfate in the same buffer as sul fite. After centrifugation at 400 x g for 10 min the supernatants were dialyzed against PBS-buffer in a dialysis tubing with a m olecular weight cut-off of 500 Da (Roth, Karlsruhe, Germ any) for 20 h to remove residual sulfite or sulfate, respectively. The elimination of the concentration of sulfite by this dialysis mem brane was more than 97%, that of PAF less than 5% and that of LTB4 less than 25%.
CL-measurements o f neutrophils with alveolar macrophage-derived supernatants
The supernatants obtained from incubations of AM with sulfite or sulfate were assayed for their ability to stimulate the respiratory burst of PMN by measuring lucigenin-dependent CL (Allen, 1981; Allen, 1982; Allen, 1986; Gyllenhammar, 1987) . PMN (1.5 x 104) were preincubated in 0.25 ml PBS buffer, pH 7, containing 0.1% glucose and 0.8 mM lucigenin for 10 min at 37 °C in a sixchannel Biolumat LB9505 (Berthold, Wildbad, Germ any). CL m easurem ents were started, the AM -derived supernatants (50 |il) were added, and CL signals of PMN were recorded for 20 min. Im mediately afterwards PMN were stimulated by PMA (50 ng), and CL was m easured again for 20 min at 37 °C using the Biolumat analyzer. Each AM -derived supernatant of an individual canine donor was analyzed at least in duplicate with PMN.
Desensitization o f neutrophil receptors
Desensitization of PMN receptors was achieved by preincubation of human PMN (1 x 105 cells/ 0.25 ml PBS-buffer) with PAF (1 x 10" 6 m ) , LTB4 (1 x 10-7 m ) , IL-8 (0.5 M-g/ml) or C5a (1 x 10~6 m ) , respectively, for 10 min at 37 °C in the Biolumat. Cytochalasin B (4 x 10~6 m ) was added and cells were incubated for further 5 min. CL m easure ments were started, AM -derived supernatants were added, and CL response of PMN was re corded for 10 min at 37 °C. Because PAF, LTB4, IL-8 and C5a are weak elicitors of the respiratory burst, CL-measurements were perform ed in the presence of cytochalasin B (4 x 10-6 m ) (H oney cutt and Niedel, 1986) with 1 x 105 PMN/0.25 ml PBS-buffer.
Inhibition o f phospholipase A 2
To study inhibition of phospholipase A 2 (PLA 2)-dependent pathways, canine AM were treated with several inhibitors of PLA 2, AA-COCF3 (1 x 10-4 m ) (Bartoli et al., 1994) , quinacrine (1 x 10~4 m ) (Tsunawaki and Nathan, 1986) or OBA A (1 x 10~5 m ) (Köhler et al., 1992) , respectively, for 25 min at 37 °C prior to incuba tion with 1 mM sulfite. The resulting supernatants were dialyzed and analyzed for their ability to stimulate the respiratory burst of PMN.
Inhibition o f 5-lipoxygenase and cyclooxygenase
To investigate inhibition of 5-lipoxygenase (5-LO)-and cyclooxygenase (C O X)-dependent path ways, canine AM were preincubated for 20 min at 37 °C with MK 8 8 6 (1 x 10-6 m ) , an inhibitor of 5-LO (Rouzer et al., 1990) , or with indomethacin (1 x 10~6 m ) , an inhibitor of COX (Shams et al., 1989) , followed by incubation with sulfite for 30 min at 37 °C. The resulting supernatants were dialyzed and estimated for their ability to activate the respiratory burst of PMN.
Statistical analysis
Statistical significance was determ ined by analy sis of variance and two-sample t-test (STAT-SAK, Version 2.12 by G. E. Dallal, 1986) . Changes with p < 0.05 were considered significant.
Results
Release o f a neutrophil-stimulating activity by sulfite-treated alveolar macrophages in comparison to sulfate-treated alveolar macrophages
To compare the effect of sulfite on the secretion of m ediators by AM with that of sulfate, canine AM were incubated with sulfite or sulfate, respec tively. Control AM were treated simultaneously. The resulting supernatants were analyzed for their ability to stimulate the respiratory burst of canine PMN by lucigenin-dependent CL measuring su peroxide anion production (Allen, 1981; Allen, 1982; Allen, 1986; Gyllenhammar, 1987) .
As seen in Fig. 1 , supernatants (conditioned su pernatant) of sulfite-treated canine AM signifi cantly increased CL of resting and PMA-stimulated canine PMN as com pared to supernatants of control AM. The PMN-stimulating activity was dependent on the sulfite concentration used for AM treatm ent showing the strongest response with 1 mM sulfite. In contrast, supernatants of AM treated with sulfate (1 m M ) did not increase CLresponse of resting or PM A-stimulated canine PMN compared to control supernatant. These findings indicate that sulfite specifically induces AM to release an activity that stimulates the respi ratory burst of PMN. Since the strongest response was obtained with 1 m M sulfite, this sulfite concen tration was used in subsequent experiments.
Characterization o f neutrophil-stimulating activity by desensitization o f neutrophil receptors
To identify the m ediators of the PMN-stimulating activity, PMN receptors for PAF, LTB4, IL-8 or C5a were desensitized with their corresponding agonists. The addition of supernatant of sulfitetreated AM should then result in a decreased CLresponse when the target receptor for the PMNstimulating activity is identical with one of the ag onists. Since supernatants of sulfite-treated AM activated not only canine but also hum an PMN (Beck-Speier et al., in press), these studies were performed with human PMN which in addition showed a stronger response to IL-8 , LTB4 or C5a than canine PMN. The optimal concentrations of PAF, LTB4, IL-8 and C5a for desensitization of their corresponding receptors were determ ined in separate experiments (data not shown). Fig. 2 shows that the PMN-stimulating activity was strongly reduced when the cells had been preincu bated with PAF or LTB4, whereas preincubation with IL-8 or C5a did not affect the stimulating ac- tivity. This suggests that the PM N-stimulating ac tivity interacts with the PAF receptor and the LTB4 receptor during activation of PMN.
Effect o f phospholipase A 2, 5-lipoxygenase and cyclooxygenase on the release o f the neutrophil-stimulating activity
Since the PMN-stimulating activity seems to contain lipid mediators such as PAF and LTB4, the activity should be reduced by inhibition of PLA 2 which is involved in the biosynthesis of both mediators. We used three inhibitors of PLA 2, AA CO CF3 (Bartoli et al., 1994) , quinacrine (Tsunawaki and Nathan, 1986) and OBAA (Köhler et al., 1992) , respectively. AM were pretreated with either one of these PLA 2 inhibitors prior to incubation with sulfite. As dem onstrated in Fig. 3 , inhibition of PLA2 in sulfite-treated AM signifi cantly reduced the release of the PMN-stimulating activity. This indicates that the PMN-stimulating activity is generated by PLA2-dependent pathways. PLA 2 hydrolyzes phospholipids to lyso-phospholipids and arachidonate, which is further m e tabolized to leukotrienes by 5-LO, prostaglandins by COX and other metabolites of arachidonic acid (Denzlinger, 1996; Holtzman, 1991) . To study which pathway is involved in the generation of the PMN-stimulating activity, prior to incubation of AM with sulfite 5-LO was inhibited by MK 8 8 6 (Rouzer et al., 1990) and COX was inhibited by indomethacin (Shams et al., 1989) in separate ex periments. As shown in Fig. 4 , inhibition of 5-LO by MK 8 8 6 in sulfite-treated AM resulted in a sig nificant reduction of the PMN-stimulating activity, whereas inhibition of COX showed no effect. This indicates that part of the PMN-stimulating activity is generated via 5-LO -dependent pathways.
Discussion
PAF and LTB4 are potent lipid m ediators in volved in a num ber of pathophysiological reac tions. In inflammatory reactions PAF is mainly synthesized by the remodeling pathway (Snyder, 1995) . This pathway results in generation of lyso-PAF through action of PLA 2 on phosphatidylcho line. Lyso-PAF is converted to PAF by acetylCoA:lyso-PAF acetyltransferase. When lyso-PAF is produced from phosphatidylcholine species con taining arachidonic acid at the sn -2 position, the arachidonic acid released is available for leukotriene synthesis (Ram esha and Pickett, 1986; Suga et al., 1990) . Arachidonic acid is converted to leukotriene A 4 (LTA4) by 5-LO acting together with 5-lipoxygenase-activating protein (Denzlinger, 1996;  Abram ovitz e t al., 1993). LTA4 can be m e tabolized to LTB4 by LTA4 hydrolase or to the cysteinyl leukotrienes by leukotriene C4 (LTC4) synthase (Denzlinger, 1996; Minami et al., 1990 ).
LTB4 is the major leukotriene product of rat and human AM (Lee and Lane, 1992) . Recently Shamsuddin et al. (1995) showed that PAF and leukotrienes can be regulated differently in rat AM.
Our present study shows that, in contrast to sul fate, sulfite induces AM to release an activity which modulates PMN function by stimulating the respiratory burst indicating that the release of a PMN-stimulating activity is specific for sulfite (Fig. 1) . Desensitization of PMN receptors showed that the PMN-stimulating activity elicits the respi ratory burst of PMN via receptors for PAF and LTB4 (Fig. 2) . These data provide indirect evi dence that the two mediators secreted by sulfitetreated AM are identical to PAF and LTB4. The existence of PAF in the PMN-stimulating activity was confirmed by PAF antagonists and by the PAF-like CL-kinetic of the PMN-stimulating activ ity after extraction of apolar lipids (Beck-Speier et al., in press ). Our studies with inhibitors of PLA 2 and 5-LO support the conclusion about the release of PAF and LTB4 induced by sulfite. Among the inhibitors of the PLA2 pathway, OBAA was most efficient in suppressing PMN-stimulating activity by more than 90% (Fig. 3) . Inhibition of PLA2 downregulates both the remodeling pathway for PAF and arachidonic acid metabolism. Looking downstream the arachidonic acid pathway, inhibi tion of 5-LO by MK 8 8 6 diminished the PMNstimulating activity in the conditioned supernatant by about 60% (Fig. 4) . This finding confirms that the formation of leukotrienes is not exclusively re sponsible for the activation of PMN, and suggests the presence of a second m ediator in the superna tant of sulfite-treated AM which does not derive from a 5-LO metabolite but which appears to be identical with PAF.
Since sulfite unlike sulfate is able to activate the respiratory burst of PMN even at very low concen trations (Beck-Speier et al., 1994) , the supernatants of sulfite-treated AM being tested with PMN were dialyzed against PBS buffer in a dialysis membrane with a m olecular weight cut-off of 500 Da to remove sulfite. The dialysis eliminated the concentration of sulfite by more than 97%, and reduced that of PAF by less than 5% and that of LTB4 by less than 25%.
The respiratory burst activity of PMN was d eter mined by superoxide dismutase-inhibitable lucigenin-dependent CL which is generated by reduc tive dioxygenation of lucigenin by superoxide anions (Allen, 1981; Allen, 1982; Allen, 1986; Gyllenhammar, 1987) . Recently it was shown that luc igenin itself can reduce oxygen to superoxide an ion in the presence of NAD H /N A D PH and reducing enzyme systems (Liochev and Fridovich, 1997; Vasquez-Vivar et al, 1997) . However, these in-vitro studies have not yet been proofed with cellular systems. The stimulation of PMN by PMA leads to an activation of NAD PH oxidase which produces superoxide anions (Bellavite, 1988) . This correlates with a strong increase of lucigenin-dependent CL compared to the CL-level of resting control cells measured prior to addition of PMA into the assay system (Beck-Speier et al, 1993) . PMN of patients with chronic granulom atous dis ease having genetic defects in their NAD PH oxi dase system cannot produce superoxide anions (Curnutte and Babior, 1987; Dinauer et al., 1987; Volpp et al, 1988) . Since the PMN of these pa tients show no increase in lucigenin-dependent CL during activation by PMA in contrast to normal PMN (Beck-Speier et al, 1993) , we conclude that lucigenin only detects superoxide anions produced by PMN. Prevention of NAPDH oxidase activa tion in PMN by inhibitors of protein kinase C com pletely abolished lucigenin-dependent CL which confirms that lucigenin can be used as a probe for detecting cell-related superoxide anion release in our system (data not shown). Therefore, although lucigenin produces superoxide anions in in-vitro systems we suggest that the lucigenin-dependent CL can be used as a differential m easurem ent for N AD PH oxidase activity by comparing the CLlevels of resting and activated cells.
PAF has been reported to be an effective m edia tor in triggering an increase in the alveolar-capillary permeability (Evans et al, 1987; O 'D onnell and Barnett, 1987; DeLima et al, 1995; Longphre and Kleeberger, 1995) . Recent findings have shown that PAF induces the transcription of vas cular endothelial growth factor in vascular smooth muscle cells which increases vascular permeability in-vivo (Nauck et al, 1997) . In addition, PAF is also known as a potent mediator for the secretion of lysosomal enzymes (Hayashi et al, 1991; Pinckard et al, 1992) . LTB4 is a potent chemotactic agent for PMN and is involved in the induction of PMN-endothelial cell adhesion (Henderson, 1994; Palmblad and Lerner, 1992) . It is also involved in increased vascular permeability (Björk et al., 1982) and in PMN degranulation (Denzlinger, 1996) . There is also evidence that PAF and LTB4 interact in mediating their effects (Denzlinger, 1996) .
Chronic exposure of dogs to a neutral sulfite aerosol alters the alveolar-capillary permeability as well as the lysosomal enzyme secretion as as sessed by determ ination of the content of protein and albumin and the extracellular activity of ß-Nacetyl-glucosaminidase in the bronchoalveolar la vage fluid (M aier et al., 1992) . Both capillary per meability and lysosomal enzyme secretion signifi cantly increased in the second half of the exposure period of one year. The data from the present invitro study suggest that PAF and LTB4 released by sulfite-treated AM may significantly contribute to the altered permeability and the increased release of lysosomal enzyme activity during exposure of dogs to a neutral sulfite aerosol. The concentration of particulate sulfite in our in-vivo study corres ponds to sulfur dioxide levels occurring during smog episodes (0.2 ppm). In our in-vitro model 0.5 to 2 mM sulfite were required to stimulate AM for the release of mediators. These concentrations are high but may be of biological relevance. Associa tion of the 4-valent sulfur with particles favors ele vated deposition in the lung periphery, while gas eous sulfur dioxide is predominantly adsorbed in the upper airways. Studies with a rat model have shown that inorganic particles are preferentially deposited in the alveolar duct bifurcations (Warheit et al., 1984; Osornio-Vargas et al., 1991) . From our in-vivo study with neutral sulfite and acidic sulfate aerosols we have indirect evidence that sulfur-related particles are enriched in this lung com partm ent indicated by epithelial type II cell prolif eration in the alveolar ducts (Takenaka et al., 1996) . Accumulation of these particles in the alve olar ducts might result in high local concentrations of sulfur-related compounds. In addition, the local concentration of sulfite is dependent on the activ ity of the sulfite-detoxifying enzyme sulfite oxi dase present in tissues or cells at the sites of par ticle deposition. Lung tissue as well as AM have very low activities of sulfite oxidase and are there fore sensitive to sulfite toxicity (Beck-Speier et al, 1985) . In summarizing the results from our in-vivo and in-vitro studies, we suppose that inhalation of sul fur dioxide/sulfite-aerosols can activate AM to re lease lipid m ediators thus contributing to initiation or amplification of inflammatory responses in the lungs.
